logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10544213 B1

PDFFull Text
Date of Patent:
Jan. 28, 2020

Filed:

Mar. 12, 2015

Compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose tolerance

Applicants:

Neurimmune Holding Ag, Schlieren, CH;

University of Zurich, Zurich, CH;

Inventors:

Jan Grimm, Dübendorf, CH;

Fabrice Heitz, Bartenheim, FR;

Fabian Wirth, St. Gallen, CH;

Tobias Welt, Zurich, CH;

Assignees:

Neurimmune Holding AG, Schlieren, CH;

University of Zurich, Zurich, CH;

Attorneys:

McDermott Will & Emery LLP

Kristina Bieker-Brady

Primary Examiner:

Daniel E Kolker

Assistant Examiner:

Aditi Dutt

Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 45/06 (2006.01); C07K 16/26 (2006.01); A01K 67/027 (2006.01); A61K 47/68 (2017.01); A61P 3/10 (2006.01); A61K 39/395 (2006.01); A61K 49/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/26 (2013.01); A01K 67/0275 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61K 47/6847 (2017.08); A61K 49/0008 (2013.01); A61P 3/10 (2018.01); A01K 2217/052 (2013.01); A01K 2227/105 (2013.01); A01K 2267/0362 (2013.01); A61K 2039/505 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01);
Abstract

Described are molecules specifically binding to human islet amyloid polypeptide (hIAPP) also known as amylin, particularly human-derived antibodies as well as fragments, derivatives and variants thereof for antagonizing islet amyloid polypeptide (IAPP) induced β-cell damage and impaired glucose tolerance which are symptoms typically associated with diabetes mellitus type 2 (T2D).

Find Patent Forward Citations

Grimm, Jan. (2020). Compounds capable of antagonizing islet amyloid polypeptide (iapp) induced beta-cell damage and impaired glucose tolerance (U.S. Patent No. 10544213). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10544213

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…